Abstract:Key PointsResveratrol, a small polyphenol, has been discovered and re-discovered as a potential therapeutic in recent years. Although putative cardioprotective effects were first noted in 1982, it was only after a 1992 report of high levels of resveratrol in red wine that these effects were investigated extensively. In 1997, resveratrol was isolated in a screen for cyclooxygenase inhibitors, and was shown to be an effective chemotherapeutic and chemopreventive agent. Moreover, in 2003, it was identified as the top hit in a screen for activators of sirtuin deacetylases and was shown to extend the lifespans of lower organisms.The number of reported effects for resveratrol is constantly growing. Many direct targets have been identified in vitro, and protective effects have been demonstrated in various rodent models of disease.Pharmacokinetic studies have consistently shown that levels of resveratrol in serum do not reach the concentrations required for most of the reported in vitro effects, or do so only transiently. In vivo evidence has therefore become increasingly important in efforts to understand how resveratrol elicits its effects in mammals.One possibility that has been suggested based on data from lower organisms is that resveratrol acts as a caloric restriction mimetic. This hypothesis is intriguing because caloric restriction seems to slow the intrinsic rate of ageing, and improve general health, rather than block specific disease processes.The many reported in vivo effects of resveratrol are reviewed here and, whenever possible, have been related to putative mechanisms and targets. Determining the mechanism(s) by which resveratrol and similar molecules act, and developing methods to improve bioavailability and/or specificity, has enormous potential to benefit human health.

Recent progress of resveratrol in anti-aging field

Multidimensional biological activities of resveratrol and its prospects and challenges in the health field

Effect of resveratrol and pterostilbene on aging and longevity

Effects and Mechanisms of Resveratrol on Aging and Age-Related Diseases

Current Update on Preclinical and Clinical Studies of Resveratrol, a Naturally Occurring Phenolic Compound

Health Benefits and Molecular Mechanisms of Resveratrol: A Narrative Review

Therapeutic potential of resveratrol: the in vivo evidence

Effects of Resveratrol Supplementation on Risk Factors of Non-Communicable Diseases: A Meta-Analysis of Randomized Controlled Trials

Resveratrol (RV): A pharmacological review and call for further research

Resveratrol and Its Effects on the Vascular System

Discovery of a 4-Hydroxy-3′-Trifluoromethoxy-Substituted Resveratrol Derivative as an Anti-Aging Agent

Latest advances and clinical application prospects of resveratrol therapy for neurocognitive disorders

Resveratrol:A review of plant sources, synthesis, stability, modification and food application.

Antioxidant effects of resveratrol in the cardiovascular system

The Effect of Resveratrol on the Cardiovascular System from Molecular Mechanisms to Clinical Results

The therapeutic potential of resveratrol: a review of clinical trials

Resveratrol: A Double-Edged Sword in Health Benefits

Derivatives of Resveratrol: Potential Agents in Prevention and Treatment of Cardiovascular Disease.

Effect of Resveratrol on Aging of Caenorhabditis Elegans

Therapeutic effects of resveratrol on epigenetic mechanisms in age-related diseases: A comprehensive review

Dietary Anti-Aging Polyphenols and Potential Mechanisms